PharmaLex (now Cencora PharmaLex)
↗Multiple global headquarters; main offices in Switzerland and US
PharmaLex is a leading global provider of specialized services for the pharmaceutical, biotech, and medical device industries, with expertise in regulatory affairs, quality management, compliance, and pharmacovigilance. Operating across the entire product lifecycle from clinical development to post-launch surveillance, PharmaLex serves over 1,000 clients worldwide through a team of scientific, regulatory, and safety experts. The company was acquired by AmerisourceBergen (now Cencora, Inc.) in January 2023 for €1.28 billion, integrating into Cencora's comprehensive life sciences services platform. PharmaLex's acquisition by Cencora positioned the company as a key component of a major global pharmaceutical distribution and biopharma services ecosystem, expanding its capabilities and market reach.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals | Biotechnology | Medical Devices | CRO (Contract Research Organization)
Sub-Industry:Regulatory Consulting | Quality Management | Pharmacovigilance | Compliance
SIZE & FINANCIALS
Employees:1001-5000
Revenue:Part of $321B+ Cencora revenue
Ownership:private (subsidiary of public parent Cencora)
Status:operating
FUNDING
Stage:Acquired/Integrated
Total Raised:Acquired for €1.28 billion
Investors:Cencora, Inc. (formerly AmerisourceBergen Corporation)
STOCK
Exchange:NYSE (parent company Cencora)
Ticker:COR (parent company)
Market Cap:$152B+ (Cencora parent)
PIPELINE
Stage:Consulting/Support across all stages - Discovery through Phase 4
Lead Drug Stage:N/A (consulting company, not a pharmaceutical manufacturer)
Modalities:Small molecule, mAb (monoclonal antibody), ADC (antibody-drug conjugate), Cell therapy, Gene therapy, Biologics, Medical devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Cencora, Inc.
Acquired By:Cencora, Inc. (formerly AmerisourceBergen Corporation) (2023-01-01)
Key Partnerships:AmerisourceBergen / Cencora (parent company), Healthcare providers worldwide, Biopharmaceutical manufacturers, Regulatory authorities (FDA, EMA, etc.)
COMPETITION
Position:Leader
Competitors:Parexel International, IQVIA, Covance (LabCorp subsidiary), Charles River Laboratories, Syneos Health
LEADERSHIP
Key Executives:
Unknown (post-Cencora integration) - Leadership under Cencora structure
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PharmaLex (now Cencora PharmaLex) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PharmaLex (now Cencora PharmaLex). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.